Vanberra Signal
Lumx logo

Lumx

Curated by Signal

Blockchain financial services platform offering secure, user-friendly solutions.

Overview

Lumx operates within the fintech ecosystem by offering a range of blockchain financial services, which include smart wallets, smart contracts, transactions, and credentials. The platform is aimed at businesses that are looking to integrate blockchain technology in a secure and cost-effective manner. It targets various industries, such as ticketing, identity verification, and loyalty programs, and seeks to address the challenges associated with adopting blockchain solutions. Lumx incorporates security measures, including Multi-Party Computation (MPC) technology. Additionally, the Lumx Protocol's API supports blockchain data analysis and integration, allowing businesses to utilize blockchain capabilities. The focus of Lumx is on security and usability in the context of enterprise blockchain technology adoption.

Key facts

Founded
2022

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Decentralized Finance companies
  • Blockchain platform enabling decentralized finance and asset tokenization services.

    Decentralized FinanceSan Marino
  • Blockchain financial services enabling real-time payments and global access.

    Decentralized FinanceZug, Switzerland
  • Crypto finance management platform simplifying operations for Web3 teams.

    Decentralized FinanceLondon, United Kingdom
+ 453 more similar companies on Signal

About Lumx

What does Lumx do?

Lumx operates within the fintech ecosystem by offering a range of blockchain financial services, which include smart wallets, smart contracts, transactions, and credentials.

Where is Lumx headquartered?

Lumx is headquartered in Rio De Janeiro, Brazil.

When was Lumx founded?

Lumx was founded in 2022.

Which sector is Lumx in?

Lumx operates in Decentralized Finance, part of Financial Technology.

Who are Lumx's competitors?

Companies similar to Lumx include Mintlayer, Liquineq, and Koshance.